Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 11, 2026
Why Is AECOM (ACM) Stock Down -9.70% Today?

Why Is AECOM (ACM) Stock Down -9.70% Today?

Key Takeaways

  • AECOM shares plunged approximately 9.70% in Tuesday's trading session, building on a 3.35% decline Monday, following the release of deeply disappointing fiscal third-quarter 2026 results.
  • The primary catalyst was a $337 million pre-tax charge tied to a troubled Construction Management project, which drove the company to a quarterly loss versus a year-ago profit.
  • AECOM slashed its full-year fiscal 2026 adjusted EPS guidance to a range of $3.95–$4.15, far below the analyst consensus of $5.97, while also trimming free cash flow expectations.
  • Multiple Wall Street analysts responded with price target cuts, including Robert W. Baird dropping its target from $87 to $73.
  • Broader market sentiment toward the engineering and construction sector remains cautious, though AECOM's record backlog of $27.8 billion offers a potential floor for long-term investors.
  • Traders are now watching for management's conference call commentary and any progress on recovering claims tied to the remaining design-build projects.

Opening Summary

ACM — AECOM, the Dallas-headquartered global infrastructure consulting firm — saw its stock crater roughly 9.70% on Tuesday, extending a punishing selloff that began in Monday's after-hours session. As of late morning trading, shares of ACM changed hands near $66.19, down from Monday's close of $73.30. The downdraft follows the release of AECOM's fiscal third-quarter 2026 results after Monday's closing bell, which revealed a sizable earnings miss, a swing to a net loss, and sharply reduced full-year guidance — all driven by a massive charge on a single construction management project that has spiraled well beyond its original timeline and budget.

Earnings Miss and the $337 Million Project Charge

The most immediate and devastating driver behind Tuesday's selloff is AECOM's Q3 FY2026 earnings report, which stunned investors with an adjusted loss of $0.50 per share — a $2.01 miss versus the $1.51 consensus estimate. Revenue fell 14.2% year over year to $3.59 billion. The company booked a $337 million pre-tax charge tied to a Construction Management project originally awarded in 2019. According to CEO Troy Rudd, the project has been plagued by subcontractor productivity rates that lagged the prior timeline, leading to delayed completion and materially higher projected costs.

On a GAAP basis, AECOM swung to a net loss of $86.7 million, compared with net income of $131.0 million in the year-ago quarter. Excluding the project charge, adjusted EPS would have been $1.49 — a respectable 11% year-over-year increase — but the optics of the headline miss overwhelmed any underlying business strength.

Guidance Slash and Cash Flow Concerns

Compounding the earnings disappointment, management sharply reduced its full-year fiscal 2026 outlook. Adjusted EPS guidance now stands at $3.95 to $4.15, a drastic cut from the previous implied range and well below Wall Street's consensus of $5.97. Free cash flow guidance was lowered to approximately $300 million, reflecting expected cash outflows on the Construction Management project through the first half of fiscal 2027.

The company also acknowledged that slower project starts in the Construction Management segment — exacerbated by ongoing military conflict in the Middle East — would weigh on net service revenue growth. Excluding the charge, management's guidance implies flat year-over-year NSR, a notable deceleration from previous expectations. The combination of a massive earnings miss and a guidance reset that effectively wiped out nearly a third of previously expected full-year profitability sent investors rushing for the exits.

Analyst Reactions and Price Target Cuts

Wall Street wasted no time recalibrating. Robert W. Baird cut its price target on ACM from $87 to $73 while maintaining a Neutral rating. Earlier in the quarter, Barclays had already trimmed its target from $110 to $90, and KeyCorp lowered its estimates ahead of the print. The rapid succession of downward revisions has eroded confidence in the stock, which now trades near its 52-week low of $66.28. Despite the carnage, the broader analyst community retains a Moderate Buy consensus with nine Buy ratings and four Holds, though average price targets — which recently hovered near $114 — appear increasingly stale following this quarter's developments.

Market Context and Trading Activity

Trading volume in ACM was exceptionally heavy. Monday's regular session already saw approximately 3.4 million shares change hands, roughly double the stock's average daily volume, as traders positioned ahead of the earnings release. Tuesday's session opened with even greater intensity as the full market digested the earnings shock. The stock gapped down sharply at the open, slicing through both its 50-day and 200-day simple moving averages. AECOM's decline stands in stark contrast to the broader S&P 500, underscoring that this was a company-specific event rather than a sector- or macro-driven move. Peers such as J (Jacobs Solutions) and FLR (Fluor) did not experience comparable selling pressure.

What Comes Next for ACM

The near-term outlook for ACM hinges on several key factors. First, investors will scrutinize management's conference call for additional color on the timeline for completing the troubled project — expected in the second quarter of fiscal 2027 — and the potential to recover a portion of the $337 million through the dispute resolution process. Second, the company's decision to exit design-build P3 projects in its Construction Management business signals a strategic pivot toward lower-risk work, though two remaining legacy projects will continue to pressure cash flow in the near term.

On the positive side, AECOM's record backlog of $27.8 billion — up 13% year over year — and a robust 1.6x book-to-burn ratio demonstrate that underlying demand for the company's core professional services remains strong. The Americas design business continues to deliver mid-single-digit organic growth, and the International segment expanded its adjusted operating margin by 240 basis points. Whether these structural strengths can offset the near-term cash flow drag and restore investor confidence will likely determine the stock's trajectory through the remainder of fiscal 2026.

Trending AI Robots

For traders seeking to navigate volatile markets with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots actively deployed across thousands of tickers. These bots employ diverse strategies, timeframes, and performance metrics, but only the strongest performers under current market conditions are featured in this dynamic, real-time ranking. Whether you prefer short-term momentum plays or longer-horizon swing strategies, the Trending AI Robots section provides a streamlined way to discover tools aligned with your trading style. Explore the page to see which AI-driven strategies are delivering results right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ACM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ACM in upward trend: 10-day moving average broke above 50-day moving average on July 29, 2026

The 10-day moving average for ACM crossed bullishly above the 50-day moving average on July 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 24, 2026. You may want to consider a long position or call options on ACM as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ACM moved above its 50-day moving average on July 24, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACM advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 275 cases where ACM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACM moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACM broke above its upper Bollinger Band on July 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.149) is normal, around the industry mean (17.280). P/E Ratio (15.303) is within average values for comparable stocks, (223.868). Projected Growth (PEG Ratio) (0.740) is also within normal values, averaging (3.129). Dividend Yield (0.016) settles around the average of (0.012) among similar stocks. P/S Ratio (0.605) is also within normal values, averaging (3.030).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are MasTec (NYSE:MTZ).

Industry description

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

Market Cap

The average market capitalization across the Engineering & Construction Industry is 8.42B. The market cap for tickers in the group ranges from 15.66K to 14.67T. WKAPF holds the highest valuation in this group at 14.67T. The lowest valued company is CIPI at 15.66K.

High and low price notable news

The average weekly price growth across all stocks in the Engineering & Construction Industry was 0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. BWMN experienced the highest price growth at 55%, while RITR experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Engineering & Construction Industry was -95%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 56
Price Growth Rating: 59
SMR Rating: 72
Profit Risk Rating: 71
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
ACM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of planning, consulting, architectural and engineering design, and program and construction management services

Industry EngineeringConstruction

Profile
Details
Industry
Engineering And Construction
Address
13355 Noel Road
Phone
+1 972 788-1000
Employees
52000
Web
https://www.aecom.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Why Is AECOM (ACM) Stock Down -9.70% Today?